“Use of Liraglutide in the Medicinal Therapeutic Approach of Non-Alcoholic Steatohepatitis (NASH)”. 2021. Research, Society and Development 10 (10): e389101018921. https://doi.org/10.33448/rsd-v10i10.18921.